Policies related to creating incentives for innovation in the life sciences.
Source-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 19, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- THORN RUN PARTNERS
- Client
- EXELIXIS
- Filing UUID
- 189c4e55-a179-4345-a474-57b0b81d8666
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Tracking implementation of prescription drug pricing policies included as part of the Inflation Reduction Act (IRA).
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.